Colwell Hilary H, Mathias Susan D, Ngo Nita H, Gitlin Matthew, Lu Z John, Knoop Teresa
Ovation Research Group, San Francisco, California, USA.
J Infus Nurs. 2007 May-Jun;30(3):153-60. doi: 10.1097/01.NAN.0000270674.13439.5b.
Cancer patients treated with parenteral chimeric or humanized monoclonal antibody agents or chemotherapy are at risk of experiencing an infusion reaction. The impact of infusion reactions can be substantial. Infusion reactions, even when mild, can be disruptive and stressful. In-person interviews with 202 nurses were conducted at the 2005 Annual Oncology Nursing Society Congress to evaluate the impact of infusion reactions on patients and nurses in the inpatient and outpatient practice settings. Results from this survey study suggest that infusion reactions have a significant negative impact on both patients and nurses.
接受肠外嵌合或人源化单克隆抗体药物或化疗治疗的癌症患者有发生输液反应的风险。输液反应的影响可能很大。输液反应即使很轻微,也可能造成干扰并带来压力。在2005年肿瘤护理学会年会上,对202名护士进行了面对面访谈,以评估输液反应对住院和门诊环境中患者及护士的影响。这项调查研究的结果表明,输液反应对患者和护士都有显著的负面影响。